Safety and immunogenicity of a novel conjugate vaccine against Salmonella Typhi and Salmonella Paratyphi A in healthy adults

Trial Identifier:	205480
Sponsor:	GlaxoSmithKline
Collaborator:	Biological E. Limited
Start Date:	November 2022
Primary Completion Date:	December 2023
Study Completion Date:	April 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Belgium	Edegem, Belgium, 2610

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.